SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 352 participants.
Also called NCT03876457
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 352 participants
- Sponsor
- Registry
-
NCT03876457
-
- Other papers using this trial's data
- Anticoagulation Use and Endovascular Thrombectomy in Patients with Large Core Stroke: A Secondary Analysis of the SELECT2 Trial
- Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled Trial
- Cerebral Edema in Patients With Large Ischemic Core After Thrombectomy: A Secondary Analysis of SELECT2 Randomized Trial
- Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions With Large Ischemic Strokes: Insights From the SELECT2 Trial
- Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial
- General vs Nongeneral Anesthesia for Endovascular Thrombectomy in Patients With Large Core Strokes: A Prespecified Secondary Analysis of SELECT2 Trial
- Sex-Based Differences in Endovascular Thrombectomy Outcomes for Large Ischemic Stroke: A SELECT2 Subanalysis
- Trial of Endovascular Thrombectomy for Large Ischemic Strokes
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Canada, New Zealand, Spain, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT03876457. Randomized; single masking; primary purpose treatment. Start 2019-10-11 (actual); primary completion 2022-11-20 (actual). Results posted on 2024-03-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
- Acronym
- SELECT2
- Condition
- Acute Ischemic Stroke
- Intervention (Device)
- Endovascular Thrombectomy
- Intervention (Other)
- Medical Management
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Collaborator
- Stryker Neurovascular
- Collaborator
- The University of Texas Health Science Center, Houston
Record details
- Record id
cardio:ct-nct03876457- Content hash
b868c8a2c1168c9f1f55579b4c14abf330877a0fa8d40883cf4f2d13a7d36687